Travere Therapeutics to Present at Upcoming Investor Conferences - May 27, 2021

SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in June:

Jefferies Virtual Healthcare Conference
Date: Wednesday, June 2, 2021
Time: 1:00 p.m. ET

JMP Securities Life Sciences Conference
Date: Wednesday, June 16, 2021
Time: 11:00 a.m. ET

BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology
Date: Tuesday, June 22, 2021
Time: 11:15 a.m. ET

Live webcasts will be available at https://ir.travere.com/events-presentations and archived replays will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com